Showing results (1701-1710 of 1,866) with videos related to

Sort By:
Pageof 187
Journal of the Neurological Sciences|February 1, 2022
Endovascular thrombectomy with and without preceding intravenous thrombolysis for treatment of large vessel anterior circulation stroke: A cross-sectional analysis of 50,000 patientsAlis J Dicpinigaitis, Chirag D Gandhi, Smit P Shah, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|March 31, 2022
An institutional report of heparin induced thrombocytopenia type II in aneurysmal subarachnoid hemorrhage patientsBoyi Li, Tolga Sursal, Erick Martinez, et al.
Nanoscale|August 18, 2025
Correction: Nanophotonics of mid-infrared plasmon-polaritons at interfaces between metals and two-dimensional crystalsFlávio H Feres, Ingrid D Barcelos, Dario A Bahamon, et al.
Cardiology in Review|July 11, 2023
Aneurysmal Subarachnoid Hemorrhage and Cardiac Related Fatality: Who Dies and Why?Farzana Khan, Forouhideh Peyvandi, Kevin Clare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineCatherine Van Poznak, Mark R Somerfield, Robert C Bast, et al.
The New England Journal of Medicine|May 16, 2019
Alpelisib for <i>PIK3CA</i>-Mutated, Hormone Receptor-Positive Advanced Breast CancerFabrice André, Eva Ciruelos, Gabor Rubovszky, et al.
Stroke|December 15, 2023
Code ICH: A Call to ActionQi Li, Aleksandra Yakhkind, Anne W Alexandrov, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 24, 2024
Tunable Phonon Polariton Hybridization in a Van der Waals Hetero-BicrystalLukas Wehmeier, Shang-Jie Yu, Xinzhong Chen, et al.
Nanoscale|October 7, 2025
Two-dimensional talc as a natural abundant ultra-broadband hyperbolic materialFlávio H Feres, Francisco C B Maia, Shu Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2020
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1F André, E M Ciruelos, D Juric, et al.
Pageof 187